Patents Assigned to Arcturus Pharmaceutical Corporation
  • Method for treating diseases mediated by proteases
    Patent number: 5637616
    Abstract: A method for the topical or systemic treatment of disorders mediated by proteases which result in skin or mucosal lesions, and in particular, pemphigus, cicatricial pemphigoid, bullous pemphigoid, lichen planus, and canker sores, is disclosed wherein the host is treated with an effective amount of N-acetyl ysteine or a derivative thereof, or its pharmaceutically acceptable salt, optionally in a pharmaceutically acceptable diluent or carrier for systemic or topical delivery.
    Type: Grant
    Filed: October 5, 1993
    Date of Patent: June 10, 1997
    Assignee: Arcturus Pharmaceutical Corporation
    Inventors: Richard J. Sharpe, Maureen H. McAloon, Stephen J. Galli, Kenneth A. Arndt